1. |
Rheumatoid arthritis therapies target TNF |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 2-2
&NA;,
Preview
|
PDF (862KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
2. |
Pharmacogenomics — hope or hype? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 3-4
Karen McClellan,
Preview
|
PDF (1533KB)
|
|
摘要:
Some time within the next millennium we will come to an age when every person can have a blood sample taken so that all their functional DNA can be resequenced and every genetic variation in functional genes can be identified to form a genome database. This prediction was made by Professor Peter Wedlund from the University of Kentucky College of Pharmacy, US, during a discussion of pharmacogenomics at the annual meeting of the American Society of Health-System Pharmacists [Las Vegas, US; Dec 1998]. He continued by saying that this database will then be accessible by physicians, pharmacists and genetic counsellors, among others, to improve healthcare in patients with genetic variations.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
3. |
Does direct-to-consumer marketing have public health value? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 4-5
&NA;,
Preview
|
PDF (1536KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
4. |
Sildenafilis government rationing ‘cruel and unethical’? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 5-5
&NA;,
Preview
|
PDF (766KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
5. |
ADA recommendationsdiabetic complications management |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 6-6
&NA;,
Preview
|
PDF (723KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 7-7
&NA;,
Preview
|
PDF (734KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 8-8
&NA;,
Preview
|
PDF (752KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
8. |
Thalidomidean angiogenesis inhibitor in multiple myeloma? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 9-10
Robert Carlson,
Preview
|
PDF (1535KB)
|
|
摘要:
The name thalidomide still stirs up memories of the teratogenic tragedies it caused when marketed as a sleeping aid decades ago. But once past those painful images, thalidomide is making a positive impression in its newfound role as an antiangiogenesis agent. These agents are hot news in the fight against cancer, as they encourage host resistance to tumour cell invasion, and/or inhibit the tumour's ability to trigger blood vessel growth. Thalidomide is being tested as a potential antineoplastic agent against various solid tumours, and a report on its use in multiple myeloma attracted considerable interest at the Chemotherapy Foundation Symposium XVI [New York, US; November 1998].
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
9. |
Oxymetholone may improve myocardial function |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 10-10
&NA;,
Preview
|
PDF (769KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1173,
1999,
Page 11-11
&NA;,
Preview
|
PDF (746KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|